Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviourHorstmann, WG. & Timens, W., Oct-1996, In : Virchows Archiv : an International Journal of Pathology. 429, 2-3, p. 83-90 8 p.
Research output: Contribution to journal › Article › Academic › peer-review
Diffuse large B-cell lymphoma of the testis is a rare tumour, often with disseminated disease. According to the Kiel Classification, these lymphomas are of centroblastic or immunoblastic type, corresponding in the Working Formulation to malignant lymphoma, large cell non-cleaved and large cell immunoblastic, respectively. Adhesive cell-cell and cell-matrix interactions are generally assumed to play an important part in the metastatic process, and to find clues to the highly malignant biological behaviour of this tumour we examined expression of integrins and other adhesion molecules on the tumour cells and the presence of matrix proteins. Few adhesion molecules appeared to be expressed. CD44 was expressed in 10/12 lymphomas, CD49/VLA-6 was positive in 5/12 cases, and CD49d/VLA-4, CD54 and CD62L were detectable in a small number (2-3) of lymphomas. All other adhesion molecules were lacking. This expression pattern is suggestive of a high metastatic potential: the tumour cells seem to be poorly attached to the extracellular matrix, to each other and to other cells (CD54-, CD11a-, CD58-). The adhesion molecules expressed, CD44, CD49f/VLA-6 and CD49d/VLA-4, have been reported to play a part in dissemination, mediating intravasation (CD49f/VLA-6) and extravasation (CD44, CD49d/VLA-4). This profile of adhesion molecules may explain, at least in part, the specific biological behaviour of these lymphomas with early and rapid dissemination.
|Number of pages||8|
|Journal||Virchows Archiv : an International Journal of Pathology|
|Publication status||Published - Oct-1996|
- testis lymphoma, non-Hodgkin's lymphoma, adhesion molecule, integrin, extracellular matrix protein, NON-HODGKINS-LYMPHOMA, HOMING RECEPTOR CD44, DIFFERENTIAL EXPRESSION, ICAM-1 CD54, LFA-1, LEUKEMIAS, LECAM-1